These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 37294251

  • 1. A Three-Year Follow-Up of Bone Density Among Thai Adolescents With Perinatally Acquired HIV After Completion of Vitamin D and Calcium Supplementation.
    Sudjaritruk T, Kanjanavanit S, Chaito T, Sricharoen N, Prasarakee C, Sarachai S, Puthanakit T.
    J Adolesc Health; 2023 Aug; 73(2):262-270. PubMed ID: 37294251
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of calcium and vitamin D supplementation on bone mineral accrual among HIV-infected Thai adolescents with low bone mineral density.
    Puthanakit T, Wittawatmongkol O, Poomlek V, Sudjaritruk T, Brukesawan C, Bunupuradah T, Sricharoenchai S, Chuanjaroen T, Prasitsuebsai W, Chokephaibulkit K.
    J Virus Erad; 2018 Jan 01; 4(1):6-11. PubMed ID: 29568546
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Randomized Placebo-Controlled Trial of Low- Versus Moderate-Dose Vitamin D3 Supplementation on Bone Mineral Density in Postmenopausal Women With HIV.
    Yin MT, RoyChoudhury A, Bucovsky M, Colon I, Ferris DC, Olender S, Agarwal S, Sharma A, Zeana C, Zingman B, Shane E.
    J Acquir Immune Defic Syndr; 2019 Mar 01; 80(3):342-349. PubMed ID: 30531305
    [Abstract] [Full Text] [Related]

  • 7. Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth.
    Eckard AR, OʼRiordan MA, Rosebush JC, Ruff JH, Chahroudi A, Labbato D, Daniels JE, Uribe-Leitz M, Tangpricha V, McComsey GA.
    J Acquir Immune Defic Syndr; 2017 Dec 15; 76(5):539-546. PubMed ID: 28902705
    [Abstract] [Full Text] [Related]

  • 8. Update: Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial.
    Dzavakwa NV, Chisenga M, McHugh G, Filteau S, Gregson CL, Kasonka L, Kranzer K, Mabuda HB, Mujuru H, Redzo N, Rowland-Jones S, Schaible UE, Simms V, Ferrand RA, VITALITY team.
    Trials; 2024 Jul 22; 25(1):499. PubMed ID: 39039558
    [Abstract] [Full Text] [Related]

  • 9. Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial.
    Arpadi SM, McMahon DJ, Abrams EJ, Bamji M, Purswani M, Engelson ES, Horlick M, Shane E.
    Am J Clin Nutr; 2012 Mar 22; 95(3):678-85. PubMed ID: 22258265
    [Abstract] [Full Text] [Related]

  • 10. Effect of high-dose cholecalciferol (vitamin D3) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial.
    Rovner AJ, Stallings VA, Rutstein R, Schall JI, Leonard MB, Zemel BS.
    Osteoporos Int; 2017 Jan 22; 28(1):201-209. PubMed ID: 27837268
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.
    Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Harris DR, Price G, Baker A, Meyer WA, Wilson CM, Hazra R, Kapogiannis BG, Mulligan K, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 109 Study Team.
    Clin Infect Dis; 2018 Jan 06; 66(2):220-228. PubMed ID: 29020329
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial.
    Dzavakwa NV, Chisenga M, McHugh G, Filteau S, Gregson CL, Kasonka L, Kranzer K, Mabuda HB, Mujuru H, Redzo N, Rowland-Jones S, Schaible UE, Simms V, Ferrand RA, VITALITY team.
    Trials; 2022 Jan 26; 23(1):78. PubMed ID: 35081986
    [Abstract] [Full Text] [Related]

  • 13. Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Sophonphan J, Ananworanich J, Puthanakit T, Bone-D study group.
    Antivir Ther; 2017 Jan 26; 22(6):471-479. PubMed ID: 27786155
    [Abstract] [Full Text] [Related]

  • 14. Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Ananworanich J, Puthanakit T, Bone-D Study Group.
    AIDS; 2016 Apr 24; 30(7):1059-67. PubMed ID: 26807972
    [Abstract] [Full Text] [Related]

  • 15. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial.
    Carlin AM, Rao DS, Yager KM, Parikh NJ, Kapke A.
    Surg Obes Relat Dis; 2009 Apr 24; 5(4):444-9. PubMed ID: 18996761
    [Abstract] [Full Text] [Related]

  • 16. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
    Taha W, Chin D, Silverberg AI, Lashiker L, Khateeb N, Anhalt H.
    Pediatrics; 2001 May 24; 107(5):E79. PubMed ID: 11331729
    [Abstract] [Full Text] [Related]

  • 17. Elevated bone turnover markers predict bone mineral density accrual in adolescents with 21-hydroxylase deficiency.
    Wiromrat P, Namphaisan P, Wongsurawat N, Panamonta O, Nasomyont N.
    Clin Endocrinol (Oxf); 2023 Nov 24; 99(5):462-469. PubMed ID: 35941818
    [Abstract] [Full Text] [Related]

  • 18. Effects of milk powder intervention on bone mineral density and indicators related to bone metabolism in Chinese adolescents.
    Lu JX, Pan H, Hu XQ, Huang ZW, Zhang Q.
    Osteoporos Int; 2019 Nov 24; 30(11):2231-2239. PubMed ID: 31375874
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T, Saksawad R, Bunupuradah T, Wittawatmongkol O, Chuanjaroen T, Ubolyam S, Chaiwatanarat T, Nakavachara P, Maleesatharn A, Chokephaibulkit K.
    J Acquir Immune Defic Syndr; 2012 Dec 01; 61(4):477-83. PubMed ID: 22918157
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and predictors of bone health among perinatally HIV-infected adolescents.
    Mahtab S, Scott C, Asafu-Agyei NAA, Machemedze T, Frigati L, Myer L, Zar HJ.
    AIDS; 2020 Nov 15; 34(14):2061-2070. PubMed ID: 32910060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.